Lawsuit on Behalf of Affymax, Inc. (AFFY) Investors Over Alleged Misleading Statements Announced by Shareholders Foundation

Lawsuit on Behalf of Affymax, Inc. (AFFY) Investors Over Alleged Misleading
Statements Announced by Shareholders Foundation

SAN DIEGO, March 4, 2013 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc.
announces that a lawsuit was filed on behalf of purchasers of Affymax, Inc.
(AFFY) common stock during the period between December 8, 2011 and February
22, 2013 over alleged violations of Federal Securities Laws by Affymax, Inc.
in connection with certain allegedly false and misleading statements.

If you purchased a significant amount of common stock of Affymax, Inc. (AFFY)
between December 8, 2011 and February 22, 2013, you have certain options and
you should contact the Shareholders Foundation, Inc. by e-mail at
mail@shareholdersfoundation.com or call +1 (858) 779-1554.

Affymax has a strategic alliance agreement with Takeda to develop and
commercialize OMONTYS Injection, which is a treatment for anemia due to
chronic kidney disease in adult patients on dialysis.

The plaintiff alleges that defendants failed to disclose that 2% of patients
who were administered Omontys experienced hypersensitivity reactions resulting
in anaphylaxis, a serious and life-threatening allergic reaction, a third of
which needed medical intervention – and that 0.02% of those administered the
drug experienced fatal anaphylaxis reactions. The plaintiff claims that
Affymax stock traded at artificially inflated prices between December 8, 2011
and February 22, 2013, reaching a high of $27.74 per share in intraday trading
on October 17, 2012.

Then, on February 23, 2013, Affymax and Takeda announce a nationwide recall of
all Lots of OMONTYS® (peginesatide) Injection. Affymax, Inc said the recall is
a result of new postmarketing reports regarding serious hypersensitivity
reactions, including anaphylaxis. The U.S. Food and Drug Administration said
it has been notified of 19 reports of anaphylaxis from dialysis centers in the
United States.

Shares of Affymax, Inc. (AFFY) dropped from $16.53 per share on February 22,
2013, to as low as $2.34 per share on February 25, 2013.

Those who purchased shares of Affymax, Inc. have certain options and should
contact the Shareholders Foundation, Inc. by e-mail at
mail@shareholdersfoundation.com or call +1 (858) 779-1554.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring
and settlement claim filing service, which does research related to
shareholder issues and informs investors of securities class actions,
settlements, judgments, and other legal related news to the stock/financial
market. The Shareholders Foundation, Inc. is not a law firm. The information
is provided as a public service. It is not intended as legal advice and should
not be relied upon.

The Shareholders Foundation, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6931

CONTACT: Shareholders Foundation, Inc.
         Trevor Allen
         +1 (858) 779-1554
         mail@shareholdersfoundation.com
         3111 Camino Del Rio North
         Suite 423
         San Diego, CA 92108

SF logo
 
Press spacebar to pause and continue. Press esc to stop.